CVE-2021-40374 — MEDIUM (5.4)

Vulnerability Description

A stored cross-site scripting (XSS) vulnerability was identified in Apperta Foundation OpenEyes 3.5.1. Updating a patient's details allows remote attackers to inject arbitrary web script or HTML via the Address1 parameter. This JavaScript then executes when the patient profile is loaded, which could be used in a XSS attack.

CVSS Score

5.4

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Apperta	Openeye	3.5.1

Related Weaknesses (CWE)

CWE-79

References

https://github.com/DCKento/CVE-2021-40374ExploitThird Party Advisory
https://openeyes.apperta.org/ProductVendor Advisory
https://github.com/DCKento/CVE-2021-40374ExploitThird Party Advisory
https://openeyes.apperta.org/ProductVendor Advisory

FAQ

What is CVE-2021-40374?

CVE-2021-40374 is a vulnerability with a CVSS score of 5.4 (MEDIUM). A stored cross-site scripting (XSS) vulnerability was identified in Apperta Foundation OpenEyes 3.5.1. Updating a patient's details allows remote attackers to inject arbitrary web script or HTML via t...

How severe is CVE-2021-40374?

CVE-2021-40374 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2021-40374?

Check the references section above for vendor advisories and patch information. Affected products include: Apperta Openeye.